Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/89905

TítuloMIRRI: The Strategic Research and Innovation Agenda for 2021-2030
Autor(es)Aznar, R.
Lima, Nelson
Soares, Luís Miguel Guimarães
Legras, J.
IS_MIRRI21 Consortium
Data12-Jun-2023
CitaçãoAznar, R.; Lima, Nelson; Soares, Luís; Legras, J.; IS_MIRRI21 Consortium, MIRRI: The Strategic Research and Innovation Agenda for 2021-2030. ICCC15 - 15th International Conference on Culture Collections. No. OL2, Braga, Portugal, June 12-16, 4, 2023.
Resumo(s)The Microbial Resource Research Infrastructure (MIRRI) is the pan-European distributed Research Infrastructure for the preservation, systematic investigation, provision and valorisation of microbial resources and biodiversity. It currently brings together around 50 microbial domain Biological Resource Centres (mBRCs), culture collections and research institutes from ten European countries and one associated country. Among them an initial group of 14 partners and 8 third-parties have been involved in the IS_MIRRI21 H2020 project running from 2020-2023 which aims at consolidating MIRRI and securing its long-term sustainability. The MIRRIs Strategic Research & Innovation Agenda (SRIA) 2021-2030 is among the key results achieved in the project. With the motto Microbial resources for a green, healthy and sustainable future the SRIA is aligned with the most relevant global and European strategic agendas and the needs of user communities, to enable them to deliver the maximum value and impacts from their projects, technologies and products. It has been stablished following an exhaustive and comprehensive exercise of self-analysis, landscape analysis and horizon scanning, anticipating future trends and priorities for research and innovation in Health & Food, Agro-Food, and Environment & Energy, in line with the UN SDGs and the Horizon Europe. Seven strategic areas have been identified which are: Research on pathogenic microorganisms and human / human-animal infectious diseases; Research & Development of new (bio)pharmaceuticals / therapeutic solutions (including antimicrobials, vaccines, phage therapies and microbiome therapeutics for human use); Research & Development of new, safe, healthy and sustainable food and feed products; Resources and methods for biological management of soils and crops; Resources and methods for biomonitoring and/or bioremediation of microbial pathogens, persistent organic pollutants and plastics in soils and waters; Research & Development of renewable biobased chemicals, materials and bioenergy sources; Rescuing and preserving microbial biodiversity. It is a living document to be revised and updated at the rhythm that the global challenges, the research and innovation landscape and the users needs will dynamically change and evolve. MIRRI has since become involved in 13 high-level European projects (100% success rate), and its position in the European Research Area has also been consolidated since its recognition in 2021 a s a Landmark i n t he H ealth & Food d omain o f t he E uropean Strategy Forum on Research Infrastructures (ESFRI) Roadmap.
TipoResumo em ata de conferência
URIhttps://hdl.handle.net/1822/89905
Versão da editorahttps://www.iccc15.com/
Arbitragem científicayes
AcessoAcesso aberto
Aparece nas coleções:CEB - Resumos em Livros de Atas / Abstracts in Proceedings

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
document_57626_1.pdf151,63 kBAdobe PDFVer/Abrir

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID